|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/513 | (2006.01) |
| A61K 31/5365 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3494972 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19151897.6 |
| Date of filing the European patent application | 2011-01-24 | |
| (97) | Date of publication of the European application | 2019-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation | 2024-03-12 |
| (30) | Number | Date | Country code |
| 29858910 P | 2010-01-27 | US |
| (72) |
UNDERWOOD, Mark Richard , US
|
| (73) |
VIIV Healthcare Company ,
251 Little Falls Drive, Wilmington, DE 19808,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Dolutegraviro ir lamivudino kompozicija ŽIV infekcijai gydyti |
| COMBINATIONS OF DOLUTEGRAVIR AND LAMIVUDINE FOR THE TREATMENT OF HIV INFECTION |
| Payment date | Validity (years) | Amount | |
| 2024-12-18 | 15 | 289.00 EUR |
| 2026-01-24 |